Q1 2026 Psychedelic Drug Development Pipeline: Bullseye Charts By Watertime - February 19, 2026 4 Q1 2026 BULLSEYE CHARTS This resource is supported by Learn More UBC partners with biopharma to modernize evidence… Source RELATED ARTICLESMORE FROM AUTHOR Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
